Peptic ulcer disease

References

• Bodemar G, Walan A. Cimetidine in the treatment of active duodenal and prepyloric ulcers. Lancet 1976: 2(7978): 161–4
   PubMed Web of Science ®Google Scholar
• Graham DY, Akdamar K, Dyck WP, et al. Healing of benign gastric ulcer: comparison of cimetidine and placebo in the United States. Ann Intern Med 1985: 102(5): 573–6
   PubMed Web of Science ®Google Scholar
• Capurso L, Dal Monte PR, Mazzeo F, et al. Comparison of cimetidine 800 mg once daily and 400 mg twice daily in acute duodenal ulceration. BMJ 1984: 289(Nov 24): 1418–20
   PubMed Web of Science ®Google Scholar
• Hirschowitz BI, Berenson MM, Berkowitz JM, et al. A multicenter study of ranitidine treatment of duodenal ulcers in the United States. J Clin Gastroenterol 1986: 8(3): 359–66
   PubMed Web of Science ®Google Scholar
• Dawson J, Jain S, Cockel R. Effect of ranitidine and cimetidine on gastric ulcer healing and recurrence. Scand J Gastroenterol 1984: 19(5): 665–8
   PubMed Web of Science ®Google Scholar
• Farley A, Lévesque D, Paré P, et al. A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcer. Am J Gastroenterol 1985: 80(9): 665–8
   PubMed Web of Science ®Google Scholar
• Gitlin N, McCullough AJ, Smith JL, et al. A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal and twice-a-day famotidine in the treatment of active duodenal ulcer disease. Gastroenterology 1987: 92(1): 48–53
   PubMed Web of Science ®Google Scholar
• McCullough AJ, Graham DY, Knuff TE, et al. Suppression of nocturnal acid secretion with famotidine accelerates gastric ulcer healing. Gastroenterology 1989: 97(4): 860–6
   PubMed Web of Science ®Google Scholar
• McCullough AJ. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease. Am J Med 1986: 81(Suppl 4B): 17–24
   PubMed Web of Science ®Google Scholar
• Levendoglu H, Mehta B, Wait C, et al. Nizatidine: a new histamine receptor blocker in the treatment of active duodenal ulcers. Am J Gastroenterol 1986: 81(12): 1167–70
   PubMed Web of Science ®Google Scholar
• Cherner JA, Cloud ML, Offen WW, et al. Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Am J Gastroenterol 1989: 84(7): 769–74
   PubMed Web of Science ®Google Scholar
• Pace F, Colombo E, Ferrara A, et al. Nizatidine and ranitidine in the short-term treatment of duodenal ulcer: a cooperative double-blind study of once-daily bedtime administration. Am J Gastroenterol 1988: 83(6): 643–5
   PubMed Web of Science ®Google Scholar
• Bardhan KD, Porro GB, Bose K, et al. A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol 1986: 8(4): 408–13
   PubMed Web of Science ®Google Scholar
• Lauritsen K, Rune SJ, Bytzer P, et al. Effect of omeprazole and cimetidine on duodenal ulcer: a double-blind comparative trial. N Engl J Med 1985: 312(Apr 11): 958–61
   PubMed Web of Science ®Google Scholar
• Wilson DE. Therapeutic aspects of prostaglandins in the treatment of peptic ulcer disease. Dig Dis Sci 1986: 31(2 Suppl): 42–46S
   Web of Science ®Google Scholar
• Lanza FL. A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects. Dig Dis Sci 1986: 31(2 Suppl): 131–6S
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D, Chapman JW, Nicholson PA. A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients. Dig Dis Sci 1986: 31(2 Suppl): 75–80S
   Web of Science ®Google Scholar
• Rydning A, Weberg R, Lange O, et al. Healing of benign gastric ulcer with low-dose antacids and fiber diet. Gastroenterology 1986: 91(1): 56–61
   PubMed Web of Science ®Google Scholar
• Peterson WL, Sturdevant RA, Frankl HD, et al. Healing of duodenal ulcer with an antacid regimen. N Engl J Med 1977: 297(7): 341–5
   PubMed Web of Science ®Google Scholar
• Isenberg JI, Peterson WL, Elashoff JD, et al. Healing of benign gastric ulcer with low-dose antacid or cimetidine: a double-blind, randomized, placebo-controlled trial. N Engl J Med 1983: 308(22): 1319–24
   PubMed Web of Science ®Google Scholar
• Lux G, Hentschel H, Rohner HG, et al. Treatment of duodenal ulcer with low-dose antacids. Scand J Gastroenterol 1986: 21(9): 1063–8
   PubMed Web of Science ®Google Scholar
• Lam SK, Lau WY, Lai CL, et al. Efficacy of sucralfate in corpus, prepyloric, and duodenal ulcer-associated gastric ulcers. Am J Med 1985: 79(Suppl 2C): 24–31
   PubMed Web of Science ®Google Scholar
• Hollander D. Efficacy of sucralfate for duodenal ulcers: a multicenter, double-blind trial. J Clin Gastroenterol 1981: 3(Suppl 2): 153–7
   PubMedGoogle Scholar
• Hallerbäck B, Anker-Hansen O, Carling L, et al. Short term treatment of gastric ulcer: a comparison of sucralfate and cimetidine. Gut 1986: 27(7): 778–83
   PubMed Web of Science ®Google Scholar
• Pym B, Sandstad J, Seville P, et al. Cost- effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology 1990: 99(1): 27–35
   PubMed Web of Science ®Google Scholar
• Kozarek R, Berenson M, Berkowitz J, et al. Maintenance therapy with ranitidine following healing of duodenal ulcer. Curr Ther Res 1985: 38(2): 341–51
   Web of Science ®Google Scholar
• Texter EC Jr, Navab F, Mantell G, et al. Maintenance therapy of duodenal ulcer with famotidine: a multicenter United States study. Am J Med 1986: 81(Suppl 4B): 25–32
   PubMed Web of Science ®Google Scholar
• Cerulli MA, Cloud ML, Offen WW, et al. Nizatidine as maintenance therapy of duodenal ulcer disease in remission. Scand J Gastroenterol 1987: 22(Suppl 136): 79–83
   Web of Science ®Google Scholar
• Korman MG, Hetzel DJ, Hansky J, et al. Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: a double-blind controlled study. Dig Dis Sci 1980: 25(2): 88–91
   PubMed Web of Science ®Google Scholar
• Behar J, Roufail W, Thomas E, et al. Efficacy of sucralfate in the prevention of recurrence of duodenal ulcers. J Clin Gastroenterol 1987: 9(Suppl l): 23–30
   PubMed Web of Science ®Google Scholar
• Rodrigo M, Berenguer J, Hinojosa J. Sucralfate and cimetidine as maintenance treatment in the prevention of duodenal ulcer recurrence. Am J Med 1987: 83(Suppl 3B): 99–104
   PubMed Web of Science ®Google Scholar
• Collen MJ, Stanczak VJ, Ciarleglio CA. Basal acid output in patients with refractory duodenal ulcer disease. (Abstr) Gastroenterology 1987: 92(5): 1351
   Web of Science ®Google Scholar
• Lam SK, Lee NW, Koo J, et al. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine. Gut 1984: 25(7): 703–6
   PubMed Web of Science ®Google Scholar
• Thomas E, Reddy KR. Nonhealing duodenal ulceration due to Candida. J Clin Gastroenterol 1983: 5(1): 55–8
   PubMed Web of Science ®Google Scholar